Atopalm Acne Controlling Lotion

Manufacturer: NeoPharm Co., Ltd.
Effective date: 2011-11-09
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:30:04

Label at a glance#

ProductAtopalm Acne Controlling

Active ingredientSALICYLIC ACID

Label structure19 sections

Dosage and administration

cleanse skin thoroughly before applying medication - cover entire affected area with a thin layer one to three times daily - because excessive drying of the skin may occur, start with one application daily, then gradually increase to 2 or 3 applications daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient..................................Purpose
Salicylic Acid 2% ..................Acne Medication

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

- avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water. - using with other topical acne medications, at the same time, or immediately following use of this product, may increase dryness or irritation of the skin. If this occurs, only one acne medication should be used unless directed by your doctor. - limit use to face and neck

Stop use and ask a doctor

OTC - STOP USE SECTION

if skin or eye irritation develops.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Ask Doctor

OTC - ASK DOCTOR SECTION

In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Other information

OTHER SAFETY INFORMATION

- store in a cool, dry place - keep outer packaging for precautions and directions

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water, Butylene Glycol, Cetyl Alcohol, Dimethicone, Glyceryl Stearate, Octyldodecanol, Polysorbate 60, Arginine, Stearic Acid, Myristoyl/Palmitoyl Oxostearamide/Arachamide MEA, Tocopheryl Acetate, Allantoin, Cholesterol, Xanthan Gum, Polyacrylamide, Methylparaben, Fragrance, Propylparaben, C13-14 Isoparaffin, Laureth-7.

Questions or information

OTC - QUESTIONS SECTION

Questions or information call toll free: 1-855 - ATOPALM

Purpose

OTC - PURPOSE SECTION

Acne Medication

Description

DESCRIPTION SECTION

US Patent # US 6221371B1 Distributed by: Neopharm USA, 1 Oyster Bay Drive, Rumson, NJ 07760 Made in Korea 75721 Quick absorbing all over face lotion has a salicylic based formula that works through the night to help visibly reduce redness and reduce the size of existing pimples.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ATOPALM ACNE CONTROLLING LOTION With US Patented MLE Technology With 2% Salicylic Acid-Acne Medication to help reduce the appearance of redness and pimple size overnight 1.3 fl oz /38.4 ml Drug Facts
Active Ingredient............................. ....................Purpose
Salicylic Acid 2% ................................. Acne Medication
Use for the treatment of acne Warnings For external use only. When using this product - avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water. - using with other topical acne medications, at the same time, or immediately following use of this product, may increase dryness or irritation of the skin. If this occurs, only one acne medication should be used unless directed by your doctor. - limit use to face and neck Stop use and ask a doctor if skin or eye irritation develops. Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately. Directions cleanse skin thoroughly before applying medication - cover entire affected area with a thin layer one to three times daily - because excessive drying of the skin may occur, start with one application daily, then gradually increase to 2 or 3 applications daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day. Other information - store in a cool, dry place - keep outer packaging for precautions and directions Questions or information call toll free: 1-855-ATOPALM Distributed by: Neopharm USA, 1 Oyster Bay Drive, Rumson, NJ 07760 Made in Korea 75721

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ATOPALM ACNE CONTROLLING LOTION US Patent # US 6221371B1 Distributed by: Neopharm USA, 1 Oyster Bay Drive, Rumson, NJ 07760 Made in Korea 75721

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ATOPALM ACNE CONTROLLING LOTION Dermatologist Tested ATOPALM ACNE CONTROLLING LOTION ATOPALM ACNE CONTROLLING LOTION 2% Salicylic Acid Acne Medication Quick absorbing all over face lotion has a salicylic based formula that works through the night to help visibly reduce redness and reduce the size of existing pimples. With US Patented M L E Technology Helps Visibly Reduce Redness and Reduce Pimple Size Overnight 1.3 fl oz /38.4 ml 8 57811 00221 7

Product Package Inner Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Atopalm Acne Inner Package

Product Package Outer Label 1

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Atopalm Acne Outer Package 1

Product Package Outer Label 2

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Atopalm Acne Outer Package 2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
103568	salicylic acid 2 % Topical Lotion	PSN	2
103568	salicylic acid 20 MG/ML Topical Lotion	SCD	2
103568	salicylic acid 2 % Topical Lotion	SY	2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
1681bc73-b05f-12c3-1075-382ae39f449c	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51141-7000-1	2019-11-13	C162847	48780-1	97449f38-cbf9-f6ea-e053-dbdaa90aa703	Atopalm Acne Controlling Lotion

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51141-7000-1	Atopalm Acne Controlling	1 in 1 CARTON	LOTION	1		2
51141-7000-1	Atopalm Acne Controlling	38.4 mL in 1 TUBE	LOTION	38.4		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51141-7000	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2	Legacy NDC, 2 package rows	20111110_3049dca0-1ce5-4dee-95c0-b3563cbc511b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	2
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	2
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	2
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	2
C13-14 ISOPARAFFIN	INACTIVE INGREDIENT	E4F12ROE70	2
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	2
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	2
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	2
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	2
MYRISTOYL/PALMITOYL OXOSTEARAMIDE/ARACHAMIDE MEA	INACTIVE INGREDIENT	1211AIM8G7	2
OCTYLDODECANOL	INACTIVE INGREDIENT	461N1O614Y	2
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD)	INACTIVE INGREDIENT	0L414VCS5Y	2
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

Atopalm Acne Controlling
SALICYLIC ACID
WATER
BUTYLENE GLYCOL
CETYL ALCOHOL
DIMETHICONE
GLYCERYL MONOSTEARATE
OCTYLDODECANOL
POLYSORBATE 60
ARGININE
STEARIC ACID
MYRISTOYL/PALMITOYL OXOSTEARAMIDE/ARACHAMIDE MEA
ALLANTOIN
CHOLESTEROL
XANTHAN GUM
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD)
METHYLPARABEN
PROPYLPARABEN
C13-14 ISOPARAFFIN
LAURETH-7

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51141-7000	51141-7000-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SALICYLIC ACID	O414PZ4LPZ	ACTIB
WATER	059QF0KO0R	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
CETYL ALCOHOL	936JST6JCN	IACT
DIMETHICONE	92RU3N3Y1O	IACT
GLYCERYL MONOSTEARATE	230OU9XXE4	IACT
OCTYLDODECANOL	461N1O614Y	IACT
POLYSORBATE 60	CAL22UVI4M	IACT
ARGININE	94ZLA3W45F	IACT
STEARIC ACID	4ELV7Z65AP	IACT
MYRISTOYL/PALMITOYL OXOSTEARAMIDE/ARACHAMIDE MEA	1211AIM8G7	IACT
ALLANTOIN	344S277G0Z	IACT
CHOLESTEROL	97C5T2UQ7J	IACT
XANTHAN GUM	TTV12P4NEE	IACT
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD)	0L414VCS5Y	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
C13-14 ISOPARAFFIN	E4F12ROE70	IACT
LAURETH-7	Z95S6G8201	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 290 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	SHAMPOO / TOPICAL	9.7 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION, CONCENTRATE / ORAL	1 mg/1ml		Exact identifier — unii candidate 79 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	SYSTEM / TRANSDERMAL	4.05 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET, DELAYED RELEASE / ORAL		80 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / INFILTRATION	0.35 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	EMULSION / ORAL	20 mg/1ml		Exact identifier — unii candidate 13 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	JELLY / NASAL	140 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	JELLY / TOPICAL		180 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION / INTRAVENOUS		790 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SUSPENSION / ORAL		360 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	PASTE, DENTIFRICE / DENTAL	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CAPSULE / ORAL		1 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET, ORALLY DISINTEGRATING / ORAL		10 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		2350 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 11 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	SUPPOSITORY / VAGINAL	0.03 mg		Exact identifier — unii candidate 13 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	PASTE, DENTIFRICE / DENTAL	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
CHOLESTEROL	CHOLESTEROL	97C5T2UQ7J	LOTION / TOPICAL		20 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	OINTMENT / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CONCENTRATE / ORAL		12 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	TABLET / ORAL	NA		Exact identifier — unii candidate 20 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	EMULSION / ORAL	NA		Exact identifier — unii candidate 26 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	SOLUTION / TOPICAL	NA		Exact identifier — unii candidate 26 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INFILTRATION		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	FILM / TRANSDERMAL	32.44 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	EMULSION / TOPICAL	0.06 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / PARENTERAL		30 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
ARGININE	ARGININE	94ZLA3W45F	INJECTION, SOLUTION / INTRAVENOUS	0.29 %w/v		Exact identifier — unii candidate 11 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	TABLET, CHEWABLE / ORAL		180 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / EPIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET, COATED / ORAL	0.8 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / TOPICAL	0.24 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET, CHEWABLE / ORAL	0.14 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		6 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / RESPIRATORY (INHALATION)	0.01 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / SUBCUTANEOUS		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	CAPSULE, DELAYED RELEASE / ORAL		15 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / SUBCUTANEOUS	0.16 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	TABLET, FILM COATED / ORAL	NA		Exact identifier — unii candidate 20 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii candidate 2 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	TABLET, EXTENDED RELEASE / ORAL	0.17 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	OINTMENT / TOPICAL	7 %w/w		Exact identifier — unii candidate 20 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	CREAM / VAGINAL		200 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION, EXTENDED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	TABLET / ORAL		56 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CREAM / VAGINAL		3 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / RECTAL		271 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / SOFT TISSUE	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
STEARIC ACID	STEARIC ACID	4ELV7Z65AP	CREAM / TOPICAL		190 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	ELIXIR / ORAL	800 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
GLYCERYL MONOSTEARATE	GLYCERYL MONOSTEARATE	230OU9XXE4	AEROSOL, FOAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 21 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION/ DROPS / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET / ORAL	0.2 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IONTOPHORESIS	0.1 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SHAMPOO / TOPICAL	0.03 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	CREAM / TOPICAL		1280 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	SUSPENSION / RECTAL		452 mg	Exact identifier — unii candidate 29 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET, EXTENDED RELEASE / ORAL	0.12 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	3.6 mg		Exact identifier — unii candidate 79 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
7504a18f-1c22-4f87-95f3-97b65a9a9976			3049dca0-1ce5-4dee-95c0-b3563cbc511b	2011-11-09	Warnings	Exact identifier spl id: 7504a18f-1c22-4f87-95f3-97b65a9a9976 spl set id: 3049dca0-1ce5-4dee-95c0-b3563cbc511b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.